Jessica Waninger

1.4k total citations
12 papers, 64 citations indexed

About

Jessica Waninger is a scholar working on Oncology, Molecular Biology and Immunology. According to data from OpenAlex, Jessica Waninger has authored 12 papers receiving a total of 64 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Oncology, 5 papers in Molecular Biology and 5 papers in Immunology. Recurrent topics in Jessica Waninger's work include Cancer Immunotherapy and Biomarkers (8 papers), CAR-T cell therapy research (4 papers) and Immunotherapy and Immune Responses (4 papers). Jessica Waninger is often cited by papers focused on Cancer Immunotherapy and Biomarkers (8 papers), CAR-T cell therapy research (4 papers) and Immunotherapy and Immune Responses (4 papers). Jessica Waninger collaborates with scholars based in United States and France. Jessica Waninger's co-authors include Michael D. Green, T. Vincent, Leslie A. Fecher, Hakan Demirci, Zoey Chopra, Christopher D. Lao, Alangoya Tezel, Sara N. Journey, Ajjai Alva and Scott A. McLean and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Frontiers in Immunology.

In The Last Decade

Jessica Waninger

11 papers receiving 63 citations

Peers

Jessica Waninger

ONCOL

IMMUN

OPHTH

PRM

Hui Yi Chew Australia

Vlad Alexandru Gâta Romania

Michael Parappilly United States

Jonas Waizenegger Germany

Salla Markkinen Finland

Rodabe Navroze Amaria United States

Adrien Procureur France

Taweevat Attaseth Thailand

Nicholas Ang United States

Jinxia Bao China

Hui Yi Chew Australia

Jessica Waninger

36 ×0.9

ONCOL

17 ×0.8

IMMUN

33 ×1.7

4 ×0.3

OPHTH

38 ×2.9

PRM

Citations per year, relative to Jessica Waninger Jessica Waninger (= 1×) peers Hui Yi Chew

Countries citing papers authored by Jessica Waninger

Since Specialization

Citations

This map shows the geographic impact of Jessica Waninger's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jessica Waninger with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jessica Waninger more than expected).

Fields of papers citing papers by Jessica Waninger

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jessica Waninger. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jessica Waninger. The network helps show where Jessica Waninger may publish in the future.

Co-authorship network of co-authors of Jessica Waninger

This figure shows the co-authorship network connecting the top 25 collaborators of Jessica Waninger. A scholar is included among the top collaborators of Jessica Waninger based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jessica Waninger. Jessica Waninger is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

12 of 12 papers shown

Waninger, Jessica, F. Yesim Demirci, & Hakan Demirci. (2024). Genetic analysis of metastatic versus nonmetastatic conjunctival melanoma using a cutaneous melanoma gene expression panel. Canadian Journal of Ophthalmology. 60(3). 170–176. 2 indexed citations

Waninger, Jessica, et al.. (2023). Neoadjuvant Immune Checkpoint Inhibition in Metastatic Conjunctival Melanoma. Ophthalmic Plastic and Reconstructive Surgery. 39(5). e152–e155. 9 indexed citations

Waninger, Jessica, et al.. (2023). Evaluation of the Prognostic Role of Liver Metastases on Patient Outcomes. The Cancer Journal. 29(5). 279–284. 7 indexed citations

Vincent, T., Yilun Sun, Merna Sitto, et al.. (2022). Early Response Assessment in Advanced Stage Melanoma Treated with Combination Ipilimumab/Nivolumab. Frontiers in Immunology. 13. 860421–860421. 3 indexed citations

Waninger, Jessica, Leslie A. Fecher, Christopher D. Lao, et al.. (2022). Prognostic Hematologic Biomarkers Following Immune Checkpoint Inhibition in Metastatic Uveal Melanoma. Cancers. 14(23). 5789–5789. 3 indexed citations

Siebenaler, Ronald F., Seema Chugh, Jessica Waninger, et al.. (2022). Argonaute 2 modulates EGFR–RAS signaling to promote mutantHRASandNRAS-driven malignancies. PNAS Nexus. 1(3). pgac084–pgac084. 4 indexed citations

Waninger, Jessica, Tyler S. Beyett, Varun V. Gadkari, et al.. (2021). Biochemical characterization of the interaction between KRAS and Argonaute 2. Biochemistry and Biophysics Reports. 29. 101191–101191. 6 indexed citations

Waninger, Jessica, T. Vincent, Sara N. Journey, et al.. (2021). Validation of the American Joint Committee on Cancer Eighth Edition Staging of Patients With Metastatic Cutaneous Melanoma Treated With Immune Checkpoint Inhibitors. JAMA Network Open. 4(3). e210980–e210980. 17 indexed citations

Vincent, T., Yilun Sun, Merna Sitto, et al.. (2021). Survival outcomes associated with fewer combination ipilimumab/nivolumab doses in advanced-stage melanoma.. Journal of Clinical Oncology. 39(15_suppl). 9549–9549.

10.

Vincent, T., Stephanie Daignault‐Newton, Jessica Waninger, et al.. (2020). The impact of BRAF mutation status on clinical outcomes with anti‐PD‐1 monotherapy versus combination ipilimumab/nivolumab in treatment‐naïve advanced stage melanoma. Pigment Cell & Melanoma Research. 34(3). 629–640. 6 indexed citations

11.

Vincent, T., Kent A. Griffith, Jessica Waninger, et al.. (2020). 241 Clinical outcomes of metastatic melanoma patients with liver metastases treated with anti-PD-1 monotherapy versus combination ipilimumab/nivolumab. SHILAP Revista de lepidopterología. A143–A144. 2 indexed citations

12.

Waninger, Jessica, Michael D. Green, Catherine Cheze Le Rest, Benjamin Rosen, & Issam El Naqa. (2019). Integrating radiomics into clinical trial design. The Quarterly Journal of Nuclear Medicine and Molecular Imaging. 63(4). 339–346. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact